Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Richen-Force Science & Technology Co., Ltd. (also known as Beijing Huagen Anbang Technology) is a leading high-tech medical enterprise specializing in the research, development, manufacturing, and commercialization of diagnostic products for gastroenterology. Founded in 2002 and headquartered in Beijing, China, the company is a global pioneer in Helicobacter pylori (H. pylori) diagnosis, holding a dominant market share in China for its 13C-Urea Breath Test (13C-UBT) systems. Its product portfolio includes 13C infrared spectrometers, urea breath test kits, Helicobacter pylori stool antigen (HpSA) diagnostic kits, capsule endoscopy systems (MiroCam), and endoscopy heat probe treatment systems. Richen-Force operates R&D and manufacturing bases across Beijing, Guangzhou, and Taizhou, and exports its products to over 70 countries and regions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 北京华亘安邦科技.